- Trials with a EudraCT protocol (178)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
178 result(s) found for: Sodium phosphate.
Displaying page 5 of 9.
EudraCT Number: 2016-002251-13 | Sponsor Protocol Number: 24052016 | Start Date*: 2016-11-09 |
Sponsor Name:Oulu university hospital | ||
Full Title: The effect of intravenous single-dose dexamethasone on pain after total knee replacement surgery. | ||
Medical condition: Patients with arthrosis of knee joint needing operative treatment i.e. arthroplasty of knee. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-002185-51 | Sponsor Protocol Number: Poplitea2017 | Start Date*: 2017-10-18 | |||||||||||
Sponsor Name:Tampere University Hospital | |||||||||||||
Full Title: Effect of perineural dexamethasone on the duration of popliteal nerve block for analgesia after ankle surgery | |||||||||||||
Medical condition: Ankle arthrosis, situation after ankle injury or malposition of ankle/foot, arthrodesis as a curative therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002924-17 | Sponsor Protocol Number: CLR_15_05 | Start Date*: 2015-11-12 |
Sponsor Name:Sun Pharma Global FZE | ||
Full Title: A Phase III, Randomized, Double-Blind, Double Dummy, Active Controlled, Multi-Center Study To Evaluate The Efficacy And Safety Of Intravenous Pegylated Liposomal Prednisolone Sodium Phosphate (Nano... | ||
Medical condition: Active Rheumatoid Arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) BE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-005887-70 | Sponsor Protocol Number: REMED | Start Date*: 2021-01-28 |
Sponsor Name:Fakultní nemocnice Brno | ||
Full Title: Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomized controlled trial | ||
Medical condition: Acute respiratory distress syndrome (ARDS) associated with COVID-19 pneumonia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001425-48 | Sponsor Protocol Number: BLUEBERRY | Start Date*: 2021-07-07 |
Sponsor Name:Division of Anaesthesiology - Department of Acute Medicine - Geneva Children's Hospital, University Hospitals of Geneva | ||
Full Title: Dexamethasone and postoperative bleeding following tonsillectomy in children | ||
Medical condition: Tonsillectomy/tonsillotomy | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-000969-37 | Sponsor Protocol Number: AN-SCD1121 | Start Date*: 2007-10-05 | |||||||||||
Sponsor Name:Anthera Pharmaceuticals Incorporated | |||||||||||||
Full Title: IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome (Dose Escalation Study: Varespladib Infusion [A-001] for the Prevention of Acute Chest Syndrome in At-Risk ... | |||||||||||||
Medical condition: Acute Chest Syndrome (ACS) in At-Risk patients with Sickle Cell Disease (SCD) and Vaso-occlusive Crisis (VOC) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000172-19 | Sponsor Protocol Number: 15-124 | Start Date*: 2017-02-20 |
Sponsor Name:RWTH Aachen University for the Medical Faculty, represented by Center for Transitional & Clinical Research Aachen (CTC-A | ||
Full Title: Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients with Type 2 Diabetes | ||
Medical condition: Patients with Type 2 diabetes mellitus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-005034-15 | Sponsor Protocol Number: DXMT | Start Date*: 2022-10-05 | |||||||||||
Sponsor Name:HOSPITAL DR JOSEP TRUETA | |||||||||||||
Full Title: EFFECT OF DEXAMETASONE ON LOWER LIMB EDEMA IN PATIENTS UNDERTAKEN FOR TOTAL HIP ARTHROPLASTY | |||||||||||||
Medical condition: POST -OPERATIVE LOWER LIMB EDEMA | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000497-30 | Sponsor Protocol Number: FIS-VED-2017-01 | Start Date*: 2018-05-28 | |||||||||||
Sponsor Name:Fundación Pública Andaluza para la Gestión en Salud de Sevilla (FISEVI) | |||||||||||||
Full Title: Phase II clinical trial to evaluate the safety and efficacy of Vedolizumab combined with antiretroviral treatment to achieve functional healing in people infected with HIV-1 without previous antire... | |||||||||||||
Medical condition: Adult patients infected with HIV and without previous antiretroviral treatment. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004152-10 | Sponsor Protocol Number: EMPATHY | Start Date*: 2020-01-30 | ||||||||||||||||
Sponsor Name:IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI | ||||||||||||||||||
Full Title: Evaluating the Short-Term Renal and Systemic Effects of SGLT2 Inhibition in Non-Diabetic Patients at Risk of Accelerated GFR Decline Because of Glomerular Hyperfiltration: a sequential OFF-ON-OFF S... | ||||||||||||||||||
Medical condition: Obesity Renal chronic disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-002518-38 | Sponsor Protocol Number: KETASONE | Start Date*: 2013-07-04 | |||||||||||
Sponsor Name:Hospital Universitari de Girona Dr. Josep Trueta | |||||||||||||
Full Title: KETAMINE AND DEXAMETHASONE IN THE MANAGEMENT OF LOW BACK PAIN DURING ARTHRODESIS | |||||||||||||
Medical condition: Pain in the lumbar arthrodesis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004207-78 | Sponsor Protocol Number: ProtokolSB1 | Start Date*: 2015-01-07 | |||||||||||||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||||||||||||
Full Title: Comparison of the effect of saphenous block with plain bupivacaine vs. protracted bupivacaine mixture as a supplement to continuos sciatic catheter after major ankle and foot surgery: a randomized ... | |||||||||||||||||||||||
Medical condition: Post-operative pain after three types of major ankle and hind foot surgery: (1) total ankle arthroplasty, (2) ankle arthrodesis or (3) subtalar arthrodesis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-003285-27 | Sponsor Protocol Number: T1565-PIV-0117 | Start Date*: 2017-09-26 | |||||||||||
Sponsor Name:Laboratoires Thea | |||||||||||||
Full Title: Clinical efficacy of topical hydrocortisone 0.335% (Softacort®) in patients with chronic dry eye disease and associated ocular surface inflammation | |||||||||||||
Medical condition: Dry Eye Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001725-75 | Sponsor Protocol Number: 2015-DFU-301 | Start Date*: 2018-12-12 |
Sponsor Name:FirstString Research, Inc. | ||
Full Title: A Phase 3, Randomized, Double-blind, Parallel-group, Vehicle controlled, Multicenter Study of the Efficacy and Safety of Granexin Gel in the Treatment of Diabetic Foot Ulcer (GAIT 1) | ||
Medical condition: Diabetic Foot Ulcer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005026-35 | Sponsor Protocol Number: 35RC14_9853_DEXA-OP | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:Centre Hospitalier Universitaire de Rennes | ||||||||||||||||||
Full Title: Study DEXA-OP. Can the dexaméthasone replace the kétoprofène in the strategy of per-operating multimodal analgesia in pediatric ambulatory surgery? A double-blind randomized comparative study. | ||||||||||||||||||
Medical condition: Per-operating analgesia, pediatric ambulatory surgery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002643-89 | Sponsor Protocol Number: PALO-05-02 | Start Date*: 2005-12-14 |
Sponsor Name:Helsinn Healthcare SA | ||
Full Title: Double-blind Study to Compare the Efficacy of Palonosetron with or without the use of Dexamethasone on Days 2 and 3, in the Prevention of Nausea and Vomiting Induced by Moderately Emetogenic Chemot... | ||
Medical condition: This is a non-inferiority study in chemotherapy-naïve female patients with breast cancer, age 18 years or older, who are scheduled to receive Moderately Emetogenic Chemotherapy (MEC). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Completed) ES (Completed) AT (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004773-27 | Sponsor Protocol Number: AALL08B1 | Start Date*: 2014-03-07 | |||||||||||
Sponsor Name:Children's Oncology Group | |||||||||||||
Full Title: Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) | |||||||||||||
Medical condition: Acute Lymphoblastic Leukemia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002476-92 | Sponsor Protocol Number: 20120215 | Start Date*: 2015-06-29 | |||||||||||||||||||||
Sponsor Name:Amgen Inc | |||||||||||||||||||||||
Full Title: A Randomized, Open-label, Controlled Phase 3 Trial to Investigate the Efficacy, Safety, and Tolerability of the BiTE® Antibody Blinatumomab as Consolidation Therapy Versus Conventional Consolidatio... | |||||||||||||||||||||||
Medical condition: Patients with Philadelphia chromosome negative (Ph-) high-risk (HR) first relapse B-precursor ALL (as defined by I-BFM SG/IntReALL criteria) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) CZ (Completed) BE (Completed) IT (Completed) SE (Completed) PT (Completed) DK (Completed) AT (Completed) GB (GB - no longer in EU/EEA) PL (Completed) ES (Ongoing) FR (Completed) NL (Completed) Outside EU/EEA GR (Completed) NO (Completed) HU (Completed) RO (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-005271-16 | Sponsor Protocol Number: 2010NE02 | Start Date*: 2012-11-29 | |||||||||||
Sponsor Name:University of Dundee & NHS Tayside | |||||||||||||
Full Title: Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis? A multicentre randomized placebo controlled trial | |||||||||||||
Medical condition: Chronic kidney disease stages 4/5 with metabolic acidosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004825-14 | Sponsor Protocol Number: D1680C00016 | Start Date*: 2016-05-04 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin, Saxagliptin Combined with Dapagliflozin, and Sitagliptin in Pat... | |||||||||||||
Medical condition: Patients with type 2 diabetes mellitus and heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) HU (Completed) BG (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
